This first installment of a six-part series—authored by Hinesh Patel, MCMI ChMC of CNM LLP, Chris Raphaely of Cozen O’Connor, Nathan Cali of NOBLE Capital Markets, and Matt Podowitz of Pathfinder Advisors—explores the timely and strategic reasons why European companies are pursuing acquisitions in the U.S. middle-market health care and life sciences (HCLS) sector. Read more.
Compliments Cozen O’Connor